secwatch.observer — SEC 8-K summary
======================================

Issuer:     Amneal Pharmaceuticals, Inc. (AMRX)
CIK:        0001723128
Form:       8-K
Filed at:   2024-05-07T23:59:59+00:00
Accession:  0001628280-24-021107
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Amneal shareholders elect all 11 directors, approve say-on-pay at annual meeting
--------------------------------------------------------------------------------

- All 11 director nominees elected; votes ranged from 238.7M (Meister) to 254.4M (Yanai) for.
- Advisory vote on NEO compensation approved with 254.4M for, 1.2M against.
- Ratification of Ernst & Young as auditor for FY2024 passed with 279.1M for, 0.6M against.
- Broker non-votes of ~24.1M shares on director election and say-on-pay proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1723128/000162828024021107/0001628280-24-021107-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1723128/000162828024021107/amrx-20240502.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-021107

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer